Activation of telomerase in BeWo cells by estrogen and 2,3,7,8- tetrachlorodibenzo-p-dioxin in co-operation with c-Myc

International Journal of Oncology

Volumn 28, Issue 1, 2006, Pages 43-51

  Sarkar, Poonam ^a,b   Shiizaki, Kazuhiro ^a   Yonemoto, Junzo ^a   Sone, Hideko ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

TCDD hTERT c Myc estrogen AhR ARNT; Telomerase

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DNA BINDING PROTEIN; ESTRADIOL; MYC PROTEIN; MYC PROTEIN, HUMAN; TELOMERASE; TERATOGENIC AGENT;

ARTICLE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHORIOCARCINOMA; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PREGNANCY; PROMOTER REGION; UTERUS CANCER;

CHORIOCARCINOMA; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ESTRADIOL; FEMALE; HUMANS; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, ARYL HYDROCARBON; TELOMERASE; TERATOGENS; TETRACHLORODIBENZODIOXIN; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 33644798623     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.1.43     Document Type: Article

References (41)

1. Yonemoto J: The effects of dioxin on reproduction and development. Ind Health 38: 259-268, 2000.
2. Moriguchi T, Motohashi H, Hosoya T, Nakajima O, Takahashi S, Ohsako S, Aoki Y, Nishimura N, Tohyama C, Fujii-Kuriyama Y and Yamamoto M: Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc Natl Acad Sci USA 100: 5652-5657, 2003.
3. IARC: Monograph on the evaluation of carcinogenic risk to humans: polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. IARC press, Geneva, pp Pages, 1997.
4. Ishimura R, Ohsako S, Kawakami T, Sakaue M, Aoki Y and Tohyama C: Altered protein profile and possible hypoxia in the placenta of 2,3,7,8- tetrachlorodibenzo-p-dioxin-exposed rats. Toxicol Appl Pharmacol 185: 197-206, 2002.
5. Davis BJ, McCurdy EA, Miller BD, Lucier GW and Tritscher AM: Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Cancer Res 60: 5414-5419, 2000.
6. Moran FM, VandeVoort CA, Overstreet JW, Lasley BL and Conley AJ: Molecular target of endocrine disruption in human luteinizing granulosa cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin: inhibition of estradiol secretion due to decreased 17alpha-hydroxylase/17,20-lyase cytochrome P450 expression. Endocrinology 144: 467-473, 2003.
7. Safe S: Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120: 1-7, 2001.
8. Whitlock JP Jr: Genetic and molecular aspects of 2,3,7,8- tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 30: 251-277, 1990.
9. Swanson HI and Bradfield CA: The AH-receptor: Genetics, structure and function. Pharmacogenetics 3: 213-230, 1993.
10. Nebert DW and Jones JE: Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int J Biochem 21: 243-252, 1989.
11. Safe SH: Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 24: 87-149, 1994.
12. Birnbaum LS: Workshop on perinatal exposure to dioxin-like compounds. V. Immunologic effects. Environ Health Perspect 103 (suppl 2): 157-160, 1995.
13. Jana NR, Sarkar S, Ishizuka M, Yonemoto J, Tohyama C and Sone H: Role of estradiol receptor-alpha in differential expression of 2,3,7,8- tetrachlorodibenzo-p-dioxin-inducible genes in the RL95-2 and KLE human endometrial cancer cell lines. Arch Biochem Biophys 368: 31-39, 1999.
14. Thomsen JS, Wang X, Hines RN and Safe S: Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 15: 933-937, 1994. (Pubitemid 24156892)
15. Wang WL, Thomsen JS, Porter W, Moore M and Safe S: Effect of transient expression of the oestrogen receptor on constitutive and inducible CYP1A1 in Hs578T human breast cancer cells. Br J Cancer 73: 316-322, 1996.
16. Sarkar S, Jana NR, Yonemoto J, Tohyama C and Sone H: Estrogen enhances induction of cytochrome P-4501A1 by 2,3,7, 8-tetrachlorodibenzo-p-dioxin in liver of female Long-Evans rats. Int J Oncol 16: 141-147, 2000.
17. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, Tohyama C, Krust A, Mimura J, Chambon P, Yanagisawa J, Fujii-Kuriyama Y and Kato S: Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 423: 545-550, 2003.
18. Chaffin CL, Peterson RE and Hutz RJ: In utero and lactational exposure of female Holtzman rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin: Modulation of the estrogen signal. Biol Reprod 55: 62-67, 1996.
19. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, Orimo A and Inoue M: Estrogen activates telomerase. Cancer Res 59: 5917-5921, 1999.
20. Greider CW and Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337, 1989.
21. Blackburn EH: Telomerases. Annu Rev Biochem 61: 113-129, 1992.
22. Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
23. Harley CB, Futcher AB and Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990.
24. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650, 1996. (Pubitemid 26043667)
25. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.
26. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
27. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J and Dalla-Favera R: Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224, 1999. (Pubitemid 29070372)
28. Rea MA, Phillips MA, Degraffenried LA, Qin Q and Rice RH: Modulation of human epidermal cell response to 2,3,7,8-tetrachlorodibenzo-p-dioxin by epidermal growth factor. Carcinogenesis 19: 479-483, 1998.
29. Jiang SW, Lloyd RV, Jin L and Eberhardt NL: Estrogen receptor expression and growth-promoting function in human choriocarcinoma cells. DNA Cell Biol 16: 969-977, 1997. (Pubitemid 27387909)
30. Lewintre EJ, Orava M and Vihko R: Regulation of 17 beta-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor-alpha in choriocarcinoma cells. Endocrinology 135: 2629-2634, 1994. (Pubitemid 24377425)
31. Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, Omine M and Ishikawa F: A novel quantitative 'stretch PCR assay', that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 13: 2265-2274, 1996.
32. Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R and Vidaud M: Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 6: 452-459, 2000.
33. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
34. Nugent CI and Lundblad V: The telomerase reverse transcriptase: components and regulation. Genes Dev 12: 1073-1085, 1998.
35. Ben-Yosef T, Yanuka O, Halle D and Benvenisty N: Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene 17: 165-171, 1998.
36. Mateyak MK, Obaya AJ, Adachi S and Sedivy JM: Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8: 1039-1048, 1997. (Pubitemid 27433292)
37. Cheng J and Malayer JR: Responses to stable ectopic estrogen receptor-beta expression in a rat fibroblast cell line. Mol Cell Endocrinol 156: 95-105, 1999. (Pubitemid 29460748)
38. Porter W, Wang F, Duan R, Qin C, Castro-Rivera E, Kim K and Safe S: Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J Mol Endocrinol 26: 31-42, 2001. (Pubitemid 32140377)
39. Shiu RP, Watson PH and Dubik D: c-myc oncogene expression in estrogen-dependent and -independent breast cancer. Clin Chem 39: 353-355, 1993.
40. Wang J, Xie LY, Allan S, Beach D and Hannon GJ: Myc activates telomerase. Genes Dev 12: 1769-1774, 1998.
41. Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH and Sonenshein GE: The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene 19: 5498-5506, 2000.